Maggie Wang

Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults

W. Blattner, D. Weiner, S. Kalams, 2012, PloS one.

Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.

Allan C. deCamp, S. Self, D. Montefiori, 2010, The Journal of infectious diseases.

Quantitative and Qualitative Differences in the T Cell Response to HIV in Uninfected Ugandans Exposed or Unexposed to HIV-Infected Partners

B. Haynes, P. Kaleebu, A. McMichael, 2013, Journal of Virology.

Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.

Xuesong Yu, Gary Li, Hongmei Gao, 2012, Journal of immunological methods.

Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.

Allan C. deCamp, S. Self, D. Montefiori, 2010, The Journal of infectious diseases.